furazolidone has been researched along with Cholangitis in 2 studies
Furazolidone: A nitrofuran derivative with antiprotozoal and antibacterial activity. Furazolidone acts by gradual inhibition of monoamine oxidase. (From Martindale, The Extra Pharmacopoeia, 30th ed, p514)
furazolidone : A member of the class of oxazolidines that is 1,3-oxazolidin-2-one in which the hydrogen attached to the nitrogen is replaced by an N-{[(5-nitro-2-furyl)methylene]amino} group. It has antibacterial and antiprotozoal properties, and is used in the treatment of giardiasis and cholera.
Cholangitis: Inflammation of the biliary ductal system (BILE DUCTS); intrahepatic, extrahepatic, or both.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| DE ROSA, F | 1 |
| Zemskov, VS | 1 |
| Shor-Chudnovskiĭ, ME | 1 |
| Iriarte, DG | 1 |
| Molochenko, LP | 1 |
2 other studies available for furazolidone and Cholangitis
| Article | Year |
|---|---|
[Furazolidone associated with glucuronolactone in the therapy of acute hepatocholangitis].
Topics: Cholangitis; Furazolidone; Glucuronates; Hepatitis; Hepatitis A; Humans; Lactones; Nitrofurans | 1960 |
[Antibiotic therapy in the surgical treatment of suppurative cholangitis].
Topics: Anti-Bacterial Agents; Cholangitis; Common Bile Duct Diseases; Drug Therapy, Combination; Enterobact | 1985 |